Safety of IGFs Clinical Studies in Patients with AD Treatments aimed at increasing circulating IGF-1 levels have demonstrated favorable safety profiles in multiple clinical trials involving patients with AD or MCI [16,17,18, 232]
AOD9604 is not FDAapproved for any medical indication, and FDA advisory documents note concerns about immunogenicity, peptide-related impurities, and lack of sufficient safety and efficacy data
BPC-157 also modulates nitric oxide (NO) synthesis pathways, contributing to both mucosal protection and systemic vascular effects
AMA/AAFP Equivalency - Providers may choose to include the following in addition to the AAFP credit statement: AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s) toward the AMA Physician's Recognition Award
Retatrutide vs tirzepatide The comparison with tirzepatide is more nuanced because tirzepatide already targets two receptors (GLP-1 and GIP)
Superoxide dismutase is an important enzyme for dismutation of superoxide radicals